Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.70T | 8.87T | 7.98T | 6.81T | 4.83T |
Gross Profit | 1.37T | 1.39T | 1.28T | 1.21T | 560.91B |
EBITDA | 954.04B | 1.16T | 1.23T | 1.01T | 382.29B |
Net Income | 350.23B | 549.37B | 694.02B | 637.32B | -32.43B |
Balance Sheet | |||||
Total Assets | 10.94T | 10.71T | 9.57T | 8.75T | 7.57T |
Cash, Cash Equivalents and Short-Term Investments | 713.95B | 482.82B | 687.96B | 572.38B | 359.46B |
Total Debt | 0.00 | 2.71T | 2.70T | 2.65T | 2.56T |
Total Liabilities | 5.04T | 5.36T | 4.92T | 4.86T | 4.44T |
Stockholders Equity | 5.38T | 4.78T | 4.18T | 3.47T | 2.76T |
Cash Flow | |||||
Free Cash Flow | 360.40B | 543.81B | 191.26B | 148.73B | -56.63B |
Operating Cash Flow | 978.59B | 1.01T | 661.27B | 615.63B | 403.19B |
Investing Cash Flow | -462.43B | -710.65B | -364.66B | -375.98B | -389.04B |
Financing Cash Flow | -313.33B | -543.95B | -197.66B | -61.30B | 52.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $32.86B | 25.36 | 6.54% | 1.54% | -10.88% | -66.97% | |
75 Outperform | $20.05B | 17.85 | 13.08% | 1.48% | -7.42% | -48.08% | |
71 Outperform | $16.78B | 27.43 | 1.64% | 2.46% | -8.83% | -43.85% | |
69 Neutral | $28.28B | 20.28 | 2.60% | 0.68% | -8.56% | 68.36% | |
68 Neutral | $20.28B | 8.43 | 6.77% | 3.71% | -5.86% | -33.57% | |
64 Neutral | $12.42B | 186.15 | 0.86% | 0.36% | -14.79% | -88.78% | |
57 Neutral | £2.58B | 5.09 | -9.48% | 4.35% | 5.28% | -6.27% |